Moderna Inc. will provide as many as 100 million doses of COVID-19 shots that specifically target variants for vaccine alliance GAVI to distribute in lower-income countries in 2023. Under the agreement, Moderna will supply these mRNA variant-targeting shots for GAVI, the Vaccine Alliance, at the lowest of its tiered prices. The shots will then be distributed to poor countries through the Covax facility, backed by the World Health Organization to ensure vaccine equity around the world, Gavi said last Monday. GAVI will also cancel the delivery of remaining volumes of vaccines under a previous agreement as health providers shift to updated shots that work specifically against COVID’s new variants.
Lalita Panicker is consulting editor, views, Hindustan Times, New Delhi